Revenue FY2025
$1.0M
Net Income
$(49.0M)
EPS (Basic)
$-0.70
Net Margin
-4880.9%
ROE
-59.2%
Total Equity
$82.0M
Shares Out
100M
Shattuck Labs, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2019–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
OrbiMed Advisors
OrbiMed Advisors
$43.8M
0.2%
—
Adage Capital Management
Adage Capital Management
$56.4M
0.1%
+74.9%
Insider Transactions
Reading stored insider transactions…